カテゴリー： 世界, 医療/バイオ, LP Information

世界の熱中症対策医薬品市場予測 2023年-2029年

【英語タイトル】Global Anti-heat Stroke Medicine Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC05392）・商品コード：LP23DC05392
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：109
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の熱中症対策医薬品市場」は、過去の販売実績から2022年の世界の熱中症対策医薬品の総販売量を検討し、2023年から2029年の予測される熱中症対策医薬品の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の熱中症対策医薬品の市場規模を掲載し、XXX百万米ドル規模の世界の熱中症対策医薬品市場の詳細な分析を提供します。本インサイトレポートは、世界の熱中症対策医薬品業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の熱中症対策医薬品市場における各社の独自のポジションをより深く理解するために、熱中症対策医薬品製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の熱中症対策医薬品市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。熱中症対策医薬品の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。熱中症対策医薬品の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。熱中症対策医薬品のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

熱中症対策医薬品の世界主要メーカーとしては、Chongqing Taiji Industry (Group) Co., Ltd.、、 Heavy Pharmaceutical Holdings、 Guangdong Nanguo Pharmaceutical Co.,Ltd.、 Shanghai Hutchison Pharmaceuticals Ltd.、 CRC Benxi Sanyao Co., Ltd. Labour Union Committee、 Guangxi Dalishen Pharmaceutical Co., Ltd、 Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.)、 Beijing Tongrentang Co., Ltd、 CSPC Ouyi Pharmaceutical Co., Ltd.、 Tasly Pharmaceutical Group Co., Ltd.、 Beijing Haiderun Pharmaceutical Co.Ltd.、 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltdなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の熱中症対策医薬品市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では熱中症対策医薬品市場をセグメンテーションし、種類別 (薬液、錠剤、カプセル、その他)、用途別 (病院、診療所、薬局、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：薬液、錠剤、カプセル、その他

・用途別区分：病院、診療所、薬局、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の熱中症対策医薬品市場の10年間の市場状況・展望は？
・世界および地域別に見た熱中症対策医薬品市場成長の要因は何か？
・熱中症対策医薬品の市場機会はエンドマーケットの規模によってどのように変化するのか？
・熱中症対策医薬品のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：熱中症対策医薬品の年間販売量2018-2029、地域別現状・将来分析
・熱中症対策医薬品の種類別セグメント：薬液、錠剤、カプセル、その他
・熱中症対策医薬品の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・熱中症対策医薬品の用途別セグメント：病院、診療所、薬局、その他
・熱中症対策医薬品の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の熱中症対策医薬品市場
・企業別のグローバル熱中症対策医薬品市場データ：2018-2023年の年間販売量、市場シェア
・企業別の熱中症対策医薬品の年間売上：2018-2023年の売上、市場シェア
・企業別の熱中症対策医薬品販売価格
・主要企業の熱中症対策医薬品生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

熱中症対策医薬品の地域別レビュー
・地域別の熱中症対策医薬品市場規模2018-2023：年間販売量、売上
・主要国別の熱中症対策医薬品市場規模2018-2023：年間販売量、売上
・南北アメリカの熱中症対策医薬品販売の成長
・アジア太平洋の熱中症対策医薬品販売の成長
・ヨーロッパの熱中症対策医薬品販売の成長
・中東・アフリカの熱中症対策医薬品販売の成長

南北アメリカ市場
・南北アメリカの国別の熱中症対策医薬品販売量、売上（2018-2023）
・南北アメリカの熱中症対策医薬品の種類別販売量
・南北アメリカの熱中症対策医薬品の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の熱中症対策医薬品販売量、売上（2018-2023）
・アジア太平洋の熱中症対策医薬品の種類別販売量
・アジア太平洋の熱中症対策医薬品の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の熱中症対策医薬品販売量、売上（2018-2023）
・ヨーロッパの熱中症対策医薬品の種類別販売量
・ヨーロッパの熱中症対策医薬品の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の熱中症対策医薬品販売量、売上（2018-2023）
・中東・アフリカの熱中症対策医薬品の種類別販売量
・中東・アフリカの熱中症対策医薬品の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・熱中症対策医薬品の製造コスト構造分析
・熱中症対策医薬品の製造プロセス分析
・熱中症対策医薬品の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・熱中症対策医薬品の主要なグローバル販売業者
・熱中症対策医薬品の主要なグローバル顧客

地域別の熱中症対策医薬品市場予測レビュー
・地域別の熱中症対策医薬品市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・熱中症対策医薬品の種類別市場規模予測
・熱中症対策医薬品の用途別市場規模予測

主要企業分析
Chongqing Taiji Industry (Group) Co., Ltd.、、 Heavy Pharmaceutical Holdings、 Guangdong Nanguo Pharmaceutical Co.,Ltd.、 Shanghai Hutchison Pharmaceuticals Ltd.、 CRC Benxi Sanyao Co., Ltd. Labour Union Committee、 Guangxi Dalishen Pharmaceutical Co., Ltd、 Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.)、 Beijing Tongrentang Co., Ltd、 CSPC Ouyi Pharmaceutical Co., Ltd.、 Tasly Pharmaceutical Group Co., Ltd.、 Beijing Haiderun Pharmaceutical Co.Ltd.、 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
・企業情報
・熱中症対策医薬品製品
・熱中症対策医薬品販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Anti-heat Stroke Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Anti-heat Stroke Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Anti-heat Stroke Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Anti-heat Stroke Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Anti-heat Stroke Medicine players cover Chongqing Taiji Industry (Group) Co., Ltd.
, Heavy Pharmaceutical Holdings, Guangdong Nanguo Pharmaceutical Co.,Ltd., Shanghai Hutchison Pharmaceuticals Ltd., CRC Benxi Sanyao Co., Ltd. Labour Union Committee, Guangxi Dalishen Pharmaceutical Co., Ltd, Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.), Beijing Tongrentang Co., Ltd and CSPC Ouyi Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Anti-heat Stroke Medicine Industry Forecast” looks at past sales and reviews total world Anti-heat Stroke Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti-heat Stroke Medicine sales for 2023 through 2029. With Anti-heat Stroke Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-heat Stroke Medicine industry.
This Insight Report provides a comprehensive analysis of the global Anti-heat Stroke Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-heat Stroke Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-heat Stroke Medicine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-heat Stroke Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-heat Stroke Medicine.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-heat Stroke Medicine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Liquid Medicine
Pill
Capsule
Others
Segmentation by application
Hospital
Clinic
Pharmacy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Chongqing Taiji Industry (Group) Co., Ltd.

Heavy Pharmaceutical Holdings
Guangdong Nanguo Pharmaceutical Co.,Ltd.
Shanghai Hutchison Pharmaceuticals Ltd.
CRC Benxi Sanyao Co., Ltd. Labour Union Committee
Guangxi Dalishen Pharmaceutical Co., Ltd
Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.)
Beijing Tongrentang Co., Ltd
CSPC Ouyi Pharmaceutical Co., Ltd.
Tasly Pharmaceutical Group Co., Ltd.
Beijing Haiderun Pharmaceutical Co.Ltd.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Key Questions Addressed in this Report
What is the 10-year outlook for the global Anti-heat Stroke Medicine market?
What factors are driving Anti-heat Stroke Medicine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-heat Stroke Medicine market opportunities vary by end market size?
How does Anti-heat Stroke Medicine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti-heat Stroke Medicine Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Anti-heat Stroke Medicine by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Anti-heat Stroke Medicine by Country/Region, 2018, 2022 & 2029
2.2 Anti-heat Stroke Medicine Segment by Type
2.2.1 Liquid Medicine
2.2.2 Pill
2.2.3 Capsule
2.2.4 Others
2.3 Anti-heat Stroke Medicine Sales by Type
2.3.1 Global Anti-heat Stroke Medicine Sales Market Share by Type (2018-2023)
2.3.2 Global Anti-heat Stroke Medicine Revenue and Market Share by Type (2018-2023)
2.3.3 Global Anti-heat Stroke Medicine Sale Price by Type (2018-2023)
2.4 Anti-heat Stroke Medicine Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Pharmacy
2.4.4 Others
2.5 Anti-heat Stroke Medicine Sales by Application
2.5.1 Global Anti-heat Stroke Medicine Sale Market Share by Application (2018-2023)
2.5.2 Global Anti-heat Stroke Medicine Revenue and Market Share by Application (2018-2023)
2.5.3 Global Anti-heat Stroke Medicine Sale Price by Application (2018-2023)
3 Global Anti-heat Stroke Medicine by Company
3.1 Global Anti-heat Stroke Medicine Breakdown Data by Company
3.1.1 Global Anti-heat Stroke Medicine Annual Sales by Company (2018-2023)
3.1.2 Global Anti-heat Stroke Medicine Sales Market Share by Company (2018-2023)
3.2 Global Anti-heat Stroke Medicine Annual Revenue by Company (2018-2023)
3.2.1 Global Anti-heat Stroke Medicine Revenue by Company (2018-2023)
3.2.2 Global Anti-heat Stroke Medicine Revenue Market Share by Company (2018-2023)
3.3 Global Anti-heat Stroke Medicine Sale Price by Company
3.4 Key Manufacturers Anti-heat Stroke Medicine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-heat Stroke Medicine Product Location Distribution
3.4.2 Players Anti-heat Stroke Medicine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Anti-heat Stroke Medicine by Geographic Region
4.1 World Historic Anti-heat Stroke Medicine Market Size by Geographic Region (2018-2023)
4.1.1 Global Anti-heat Stroke Medicine Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Anti-heat Stroke Medicine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Anti-heat Stroke Medicine Market Size by Country/Region (2018-2023)
4.2.1 Global Anti-heat Stroke Medicine Annual Sales by Country/Region (2018-2023)
4.2.2 Global Anti-heat Stroke Medicine Annual Revenue by Country/Region (2018-2023)
4.3 Americas Anti-heat Stroke Medicine Sales Growth
4.4 APAC Anti-heat Stroke Medicine Sales Growth
4.5 Europe Anti-heat Stroke Medicine Sales Growth
4.6 Middle East & Africa Anti-heat Stroke Medicine Sales Growth
5 Americas
5.1 Americas Anti-heat Stroke Medicine Sales by Country
5.1.1 Americas Anti-heat Stroke Medicine Sales by Country (2018-2023)
5.1.2 Americas Anti-heat Stroke Medicine Revenue by Country (2018-2023)
5.2 Americas Anti-heat Stroke Medicine Sales by Type
5.3 Americas Anti-heat Stroke Medicine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-heat Stroke Medicine Sales by Region
6.1.1 APAC Anti-heat Stroke Medicine Sales by Region (2018-2023)
6.1.2 APAC Anti-heat Stroke Medicine Revenue by Region (2018-2023)
6.2 APAC Anti-heat Stroke Medicine Sales by Type
6.3 APAC Anti-heat Stroke Medicine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Anti-heat Stroke Medicine by Country
7.1.1 Europe Anti-heat Stroke Medicine Sales by Country (2018-2023)
7.1.2 Europe Anti-heat Stroke Medicine Revenue by Country (2018-2023)
7.2 Europe Anti-heat Stroke Medicine Sales by Type
7.3 Europe Anti-heat Stroke Medicine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anti-heat Stroke Medicine by Country
8.1.1 Middle East & Africa Anti-heat Stroke Medicine Sales by Country (2018-2023)
8.1.2 Middle East & Africa Anti-heat Stroke Medicine Revenue by Country (2018-2023)
8.2 Middle East & Africa Anti-heat Stroke Medicine Sales by Type
8.3 Middle East & Africa Anti-heat Stroke Medicine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-heat Stroke Medicine
10.3 Manufacturing Process Analysis of Anti-heat Stroke Medicine
10.4 Industry Chain Structure of Anti-heat Stroke Medicine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-heat Stroke Medicine Distributors
11.3 Anti-heat Stroke Medicine Customer
12 World Forecast Review for Anti-heat Stroke Medicine by Geographic Region
12.1 Global Anti-heat Stroke Medicine Market Size Forecast by Region
12.1.1 Global Anti-heat Stroke Medicine Forecast by Region (2024-2029)
12.1.2 Global Anti-heat Stroke Medicine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anti-heat Stroke Medicine Forecast by Type
12.7 Global Anti-heat Stroke Medicine Forecast by Application
13 Key Players Analysis
13.1 Chongqing Taiji Industry (Group) Co., Ltd.

13.1.1 Chongqing Taiji Industry (Group) Co., Ltd.
Company Information
13.1.2 Chongqing Taiji Industry (Group) Co., Ltd.
Anti-heat Stroke Medicine Product Portfolios and Specifications
13.1.3 Chongqing Taiji Industry (Group) Co., Ltd.
Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Chongqing Taiji Industry (Group) Co., Ltd.
Main Business Overview
13.1.5 Chongqing Taiji Industry (Group) Co., Ltd.
Latest Developments
13.2 Heavy Pharmaceutical Holdings
13.2.1 Heavy Pharmaceutical Holdings Company Information
13.2.2 Heavy Pharmaceutical Holdings Anti-heat Stroke Medicine Product Portfolios and Specifications
13.2.3 Heavy Pharmaceutical Holdings Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Heavy Pharmaceutical Holdings Main Business Overview
13.2.5 Heavy Pharmaceutical Holdings Latest Developments
13.3 Guangdong Nanguo Pharmaceutical Co.,Ltd.
13.3.1 Guangdong Nanguo Pharmaceutical Co.,Ltd. Company Information
13.3.2 Guangdong Nanguo Pharmaceutical Co.,Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
13.3.3 Guangdong Nanguo Pharmaceutical Co.,Ltd. Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Guangdong Nanguo Pharmaceutical Co.,Ltd. Main Business Overview
13.3.5 Guangdong Nanguo Pharmaceutical Co.,Ltd. Latest Developments
13.4 Shanghai Hutchison Pharmaceuticals Ltd.
13.4.1 Shanghai Hutchison Pharmaceuticals Ltd. Company Information
13.4.2 Shanghai Hutchison Pharmaceuticals Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
13.4.3 Shanghai Hutchison Pharmaceuticals Ltd. Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Shanghai Hutchison Pharmaceuticals Ltd. Main Business Overview
13.4.5 Shanghai Hutchison Pharmaceuticals Ltd. Latest Developments
13.5 CRC Benxi Sanyao Co., Ltd. Labour Union Committee
13.5.1 CRC Benxi Sanyao Co., Ltd. Labour Union Committee Company Information
13.5.2 CRC Benxi Sanyao Co., Ltd. Labour Union Committee Anti-heat Stroke Medicine Product Portfolios and Specifications
13.5.3 CRC Benxi Sanyao Co., Ltd. Labour Union Committee Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 CRC Benxi Sanyao Co., Ltd. Labour Union Committee Main Business Overview
13.5.5 CRC Benxi Sanyao Co., Ltd. Labour Union Committee Latest Developments
13.6 Guangxi Dalishen Pharmaceutical Co., Ltd
13.6.1 Guangxi Dalishen Pharmaceutical Co., Ltd Company Information
13.6.2 Guangxi Dalishen Pharmaceutical Co., Ltd Anti-heat Stroke Medicine Product Portfolios and Specifications
13.6.3 Guangxi Dalishen Pharmaceutical Co., Ltd Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Guangxi Dalishen Pharmaceutical Co., Ltd Main Business Overview
13.6.5 Guangxi Dalishen Pharmaceutical Co., Ltd Latest Developments
13.7 Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.)
13.7.1 Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Company Information
13.7.2 Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Anti-heat Stroke Medicine Product Portfolios and Specifications
13.7.3 Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Main Business Overview
13.7.5 Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Latest Developments
13.8 Beijing Tongrentang Co., Ltd
13.8.1 Beijing Tongrentang Co., Ltd Company Information
13.8.2 Beijing Tongrentang Co., Ltd Anti-heat Stroke Medicine Product Portfolios and Specifications
13.8.3 Beijing Tongrentang Co., Ltd Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Beijing Tongrentang Co., Ltd Main Business Overview
13.8.5 Beijing Tongrentang Co., Ltd Latest Developments
13.9 CSPC Ouyi Pharmaceutical Co., Ltd.
13.9.1 CSPC Ouyi Pharmaceutical Co., Ltd. Company Information
13.9.2 CSPC Ouyi Pharmaceutical Co., Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
13.9.3 CSPC Ouyi Pharmaceutical Co., Ltd. Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 CSPC Ouyi Pharmaceutical Co., Ltd. Main Business Overview
13.9.5 CSPC Ouyi Pharmaceutical Co., Ltd. Latest Developments
13.10 Tasly Pharmaceutical Group Co., Ltd.
13.10.1 Tasly Pharmaceutical Group Co., Ltd. Company Information
13.10.2 Tasly Pharmaceutical Group Co., Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
13.10.3 Tasly Pharmaceutical Group Co., Ltd. Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Tasly Pharmaceutical Group Co., Ltd. Main Business Overview
13.10.5 Tasly Pharmaceutical Group Co., Ltd. Latest Developments
13.11 Beijing Haiderun Pharmaceutical Co.Ltd.
13.11.1 Beijing Haiderun Pharmaceutical Co.Ltd. Company Information
13.11.2 Beijing Haiderun Pharmaceutical Co.Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
13.11.3 Beijing Haiderun Pharmaceutical Co.Ltd. Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Beijing Haiderun Pharmaceutical Co.Ltd. Main Business Overview
13.11.5 Beijing Haiderun Pharmaceutical Co.Ltd. Latest Developments
13.12 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
13.12.1 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Company Information
13.12.2 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-heat Stroke Medicine Product Portfolios and Specifications
13.12.3 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-heat Stroke Medicine Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Main Business Overview
13.12.5 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Anti-heat Stroke Medicine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Anti-heat Stroke Medicine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Liquid Medicine
Table 4. Major Players of Pill
Table 5. Major Players of Capsule
Table 6. Major Players of Others
Table 7. Global Anti-heat Stroke Medicine Sales by Type (2018-2023) & (K Units)
Table 8. Global Anti-heat Stroke Medicine Sales Market Share by Type (2018-2023)
Table 9. Global Anti-heat Stroke Medicine Revenue by Type (2018-2023) & ($ million)
Table 10. Global Anti-heat Stroke Medicine Revenue Market Share by Type (2018-2023)
Table 11. Global Anti-heat Stroke Medicine Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Anti-heat Stroke Medicine Sales by Application (2018-2023) & (K Units)
Table 13. Global Anti-heat Stroke Medicine Sales Market Share by Application (2018-2023)
Table 14. Global Anti-heat Stroke Medicine Revenue by Application (2018-2023)
Table 15. Global Anti-heat Stroke Medicine Revenue Market Share by Application (2018-2023)
Table 16. Global Anti-heat Stroke Medicine Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Anti-heat Stroke Medicine Sales by Company (2018-2023) & (K Units)
Table 18. Global Anti-heat Stroke Medicine Sales Market Share by Company (2018-2023)
Table 19. Global Anti-heat Stroke Medicine Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Anti-heat Stroke Medicine Revenue Market Share by Company (2018-2023)
Table 21. Global Anti-heat Stroke Medicine Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Anti-heat Stroke Medicine Producing Area Distribution and Sales Area
Table 23. Players Anti-heat Stroke Medicine Products Offered
Table 24. Anti-heat Stroke Medicine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Anti-heat Stroke Medicine Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Anti-heat Stroke Medicine Sales Market Share Geographic Region (2018-2023)
Table 29. Global Anti-heat Stroke Medicine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Anti-heat Stroke Medicine Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Anti-heat Stroke Medicine Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Anti-heat Stroke Medicine Sales Market Share by Country/Region (2018-2023)
Table 33. Global Anti-heat Stroke Medicine Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Anti-heat Stroke Medicine Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Anti-heat Stroke Medicine Sales by Country (2018-2023) & (K Units)
Table 36. Americas Anti-heat Stroke Medicine Sales Market Share by Country (2018-2023)
Table 37. Americas Anti-heat Stroke Medicine Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Anti-heat Stroke Medicine Revenue Market Share by Country (2018-2023)
Table 39. Americas Anti-heat Stroke Medicine Sales by Type (2018-2023) & (K Units)
Table 40. Americas Anti-heat Stroke Medicine Sales by Application (2018-2023) & (K Units)
Table 41. APAC Anti-heat Stroke Medicine Sales by Region (2018-2023) & (K Units)
Table 42. APAC Anti-heat Stroke Medicine Sales Market Share by Region (2018-2023)
Table 43. APAC Anti-heat Stroke Medicine Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Anti-heat Stroke Medicine Revenue Market Share by Region (2018-2023)
Table 45. APAC Anti-heat Stroke Medicine Sales by Type (2018-2023) & (K Units)
Table 46. APAC Anti-heat Stroke Medicine Sales by Application (2018-2023) & (K Units)
Table 47. Europe Anti-heat Stroke Medicine Sales by Country (2018-2023) & (K Units)
Table 48. Europe Anti-heat Stroke Medicine Sales Market Share by Country (2018-2023)
Table 49. Europe Anti-heat Stroke Medicine Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Anti-heat Stroke Medicine Revenue Market Share by Country (2018-2023)
Table 51. Europe Anti-heat Stroke Medicine Sales by Type (2018-2023) & (K Units)
Table 52. Europe Anti-heat Stroke Medicine Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Anti-heat Stroke Medicine Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Anti-heat Stroke Medicine Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Anti-heat Stroke Medicine Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Anti-heat Stroke Medicine Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Anti-heat Stroke Medicine Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Anti-heat Stroke Medicine Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Anti-heat Stroke Medicine
Table 60. Key Market Challenges & Risks of Anti-heat Stroke Medicine
Table 61. Key Industry Trends of Anti-heat Stroke Medicine
Table 62. Anti-heat Stroke Medicine Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Anti-heat Stroke Medicine Distributors List
Table 65. Anti-heat Stroke Medicine Customer List
Table 66. Global Anti-heat Stroke Medicine Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Anti-heat Stroke Medicine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Anti-heat Stroke Medicine Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Anti-heat Stroke Medicine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Anti-heat Stroke Medicine Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Anti-heat Stroke Medicine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Anti-heat Stroke Medicine Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Anti-heat Stroke Medicine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Anti-heat Stroke Medicine Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Anti-heat Stroke Medicine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Anti-heat Stroke Medicine Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Anti-heat Stroke Medicine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Anti-heat Stroke Medicine Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Anti-heat Stroke Medicine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Chongqing Taiji Industry (Group) Co., Ltd.
Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 81. Chongqing Taiji Industry (Group) Co., Ltd.
Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 82. Chongqing Taiji Industry (Group) Co., Ltd.
Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Chongqing Taiji Industry (Group) Co., Ltd.
Main Business
Table 84. Chongqing Taiji Industry (Group) Co., Ltd.
Latest Developments
Table 85. Heavy Pharmaceutical Holdings Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 86. Heavy Pharmaceutical Holdings Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 87. Heavy Pharmaceutical Holdings Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Heavy Pharmaceutical Holdings Main Business
Table 89. Heavy Pharmaceutical Holdings Latest Developments
Table 90. Guangdong Nanguo Pharmaceutical Co.,Ltd. Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 91. Guangdong Nanguo Pharmaceutical Co.,Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 92. Guangdong Nanguo Pharmaceutical Co.,Ltd. Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Guangdong Nanguo Pharmaceutical Co.,Ltd. Main Business
Table 94. Guangdong Nanguo Pharmaceutical Co.,Ltd. Latest Developments
Table 95. Shanghai Hutchison Pharmaceuticals Ltd. Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 96. Shanghai Hutchison Pharmaceuticals Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 97. Shanghai Hutchison Pharmaceuticals Ltd. Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Shanghai Hutchison Pharmaceuticals Ltd. Main Business
Table 99. Shanghai Hutchison Pharmaceuticals Ltd. Latest Developments
Table 100. CRC Benxi Sanyao Co., Ltd. Labour Union Committee Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 101. CRC Benxi Sanyao Co., Ltd. Labour Union Committee Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 102. CRC Benxi Sanyao Co., Ltd. Labour Union Committee Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. CRC Benxi Sanyao Co., Ltd. Labour Union Committee Main Business
Table 104. CRC Benxi Sanyao Co., Ltd. Labour Union Committee Latest Developments
Table 105. Guangxi Dalishen Pharmaceutical Co., Ltd Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 106. Guangxi Dalishen Pharmaceutical Co., Ltd Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 107. Guangxi Dalishen Pharmaceutical Co., Ltd Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Guangxi Dalishen Pharmaceutical Co., Ltd Main Business
Table 109. Guangxi Dalishen Pharmaceutical Co., Ltd Latest Developments
Table 110. Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 111. Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 112. Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Main Business
Table 114. Tianjin Zhongxin Pharmaceutical Group Co.,Ltd.) Latest Developments
Table 115. Beijing Tongrentang Co., Ltd Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 116. Beijing Tongrentang Co., Ltd Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 117. Beijing Tongrentang Co., Ltd Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Beijing Tongrentang Co., Ltd Main Business
Table 119. Beijing Tongrentang Co., Ltd Latest Developments
Table 120. CSPC Ouyi Pharmaceutical Co., Ltd. Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 121. CSPC Ouyi Pharmaceutical Co., Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 122. CSPC Ouyi Pharmaceutical Co., Ltd. Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. CSPC Ouyi Pharmaceutical Co., Ltd. Main Business
Table 124. CSPC Ouyi Pharmaceutical Co., Ltd. Latest Developments
Table 125. Tasly Pharmaceutical Group Co., Ltd. Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 126. Tasly Pharmaceutical Group Co., Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 127. Tasly Pharmaceutical Group Co., Ltd. Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Tasly Pharmaceutical Group Co., Ltd. Main Business
Table 129. Tasly Pharmaceutical Group Co., Ltd. Latest Developments
Table 130. Beijing Haiderun Pharmaceutical Co.Ltd. Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 131. Beijing Haiderun Pharmaceutical Co.Ltd. Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 132. Beijing Haiderun Pharmaceutical Co.Ltd. Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Beijing Haiderun Pharmaceutical Co.Ltd. Main Business
Table 134. Beijing Haiderun Pharmaceutical Co.Ltd. Latest Developments
Table 135. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Basic Information, Anti-heat Stroke Medicine Manufacturing Base, Sales Area and Its Competitors
Table 136. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-heat Stroke Medicine Product Portfolios and Specifications
Table 137. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-heat Stroke Medicine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Main Business
Table 139. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Latest Developments
List of Figures
Figure 1. Picture of Anti-heat Stroke Medicine
Figure 2. Anti-heat Stroke Medicine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-heat Stroke Medicine Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Anti-heat Stroke Medicine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Anti-heat Stroke Medicine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Liquid Medicine
Figure 10. Product Picture of Pill
Figure 11. Product Picture of Capsule
Figure 12. Product Picture of Others
Figure 13. Global Anti-heat Stroke Medicine Sales Market Share by Type in 2022
Figure 14. Global Anti-heat Stroke Medicine Revenue Market Share by Type (2018-2023)
Figure 15. Anti-heat Stroke Medicine Consumed in Hospital
Figure 16. Global Anti-heat Stroke Medicine Market: Hospital (2018-2023) & (K Units)
Figure 17. Anti-heat Stroke Medicine Consumed in Clinic
Figure 18. Global Anti-heat Stroke Medicine Market: Clinic (2018-2023) & (K Units)
Figure 19. Anti-heat Stroke Medicine Consumed in Pharmacy
Figure 20. Global Anti-heat Stroke Medicine Market: Pharmacy (2018-2023) & (K Units)
Figure 21. Anti-heat Stroke Medicine Consumed in Others
Figure 22. Global Anti-heat Stroke Medicine Market: Others (2018-2023) & (K Units)
Figure 23. Global Anti-heat Stroke Medicine Sales Market Share by Application (2022)
Figure 24. Global Anti-heat Stroke Medicine Revenue Market Share by Application in 2022
Figure 25. Anti-heat Stroke Medicine Sales Market by Company in 2022 (K Units)
Figure 26. Global Anti-heat Stroke Medicine Sales Market Share by Company in 2022
Figure 27. Anti-heat Stroke Medicine Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Anti-heat Stroke Medicine Revenue Market Share by Company in 2022
Figure 29. Global Anti-heat Stroke Medicine Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Anti-heat Stroke Medicine Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Anti-heat Stroke Medicine Sales 2018-2023 (K Units)
Figure 32. Americas Anti-heat Stroke Medicine Revenue 2018-2023 ($ Millions)
Figure 33. APAC Anti-heat Stroke Medicine Sales 2018-2023 (K Units)
Figure 34. APAC Anti-heat Stroke Medicine Revenue 2018-2023 ($ Millions)
Figure 35. Europe Anti-heat Stroke Medicine Sales 2018-2023 (K Units)
Figure 36. Europe Anti-heat Stroke Medicine Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Anti-heat Stroke Medicine Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Anti-heat Stroke Medicine Revenue 2018-2023 ($ Millions)
Figure 39. Americas Anti-heat Stroke Medicine Sales Market Share by Country in 2022
Figure 40. Americas Anti-heat Stroke Medicine Revenue Market Share by Country in 2022
Figure 41. Americas Anti-heat Stroke Medicine Sales Market Share by Type (2018-2023)
Figure 42. Americas Anti-heat Stroke Medicine Sales Market Share by Application (2018-2023)
Figure 43. United States Anti-heat Stroke Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Anti-heat Stroke Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Anti-heat Stroke Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Anti-heat Stroke Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Anti-heat Stroke Medicine Sales Market Share by Region in 2022
Figure 48. APAC Anti-heat Stroke Medicine Revenue Market Share by Regions in 2022
Figure 49. APAC Anti-heat Stroke Medicine Sales Market Share by Type (2018-2023)
Figure 50. APAC Anti-heat Stroke Medicine Sales Market Share by Application (2018-2023)
Figure 51. China Anti-heat Stroke Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Anti-heat Stroke Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Anti-heat Stroke Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Anti-heat Stroke Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Anti-heat Stroke Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Anti-heat Stroke Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Anti-heat Stroke Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Anti-heat Stroke Medicine Sales Market Share by Country in 2022
Figure 59. Europe Anti-heat Stroke Medicine Revenue Market Share by Country in 2022
Figure 60. Europe Anti-heat Stroke Medicine Sales Market Share by Type (2018-2023)
Figure 61. Europe Anti-heat Stroke Medicine Sales Market Share by Application (2018-2023)
Figure 62. Germany Anti-heat Stroke Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Anti-heat Stroke Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Anti-heat Stroke Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Anti-heat Stroke Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Anti-heat Stroke Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Anti-heat Stroke Medicine Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Anti-heat Stroke Medicine Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Anti-heat Stroke Medicine Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Anti-heat Stroke Medicine Sales Market Share by Application (2018-2023)
Figure 71. Egypt Anti-heat Stroke Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Anti-heat Stroke Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Anti-heat Stroke Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Anti-heat Stroke Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Anti-heat Stroke Medicine Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Anti-heat Stroke Medicine in 2022
Figure 77. Manufacturing Process Analysis of Anti-heat Stroke Medicine
Figure 78. Industry Chain Structure of Anti-heat Stroke Medicine
Figure 79. Channels of Distribution
Figure 80. Global Anti-heat Stroke Medicine Sales Market Forecast by Region (2024-2029)
Figure 81. Global Anti-heat Stroke Medicine Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Anti-heat Stroke Medicine Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Anti-heat Stroke Medicine Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Anti-heat Stroke Medicine Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Anti-heat Stroke Medicine Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の熱中症対策医薬品市場予測 2023年-2029年] (コード：LP23DC05392)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の熱中症対策医薬品市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の抗アレルギー薬市場予測 2023年-2029年
  • 世界の伝統漢方薬点滴丸薬市場予測 2023年-2029年
  • 世界の密閉型耐穿刺静脈留置針市場予測 2023年-2029年
  • 世界の抗勃起不全（ED）薬市場予測 2023年-2029年
  • 世界のアンチエイジング漢方薬市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆